EL
56
3
JWN
73
-3
ADSK
57
5
YUM
62
4
SYF
85
-5
DVA
75
2
IR
85
5
TRV
45
-4
ZTS
63
3
AN
61
-2
GPC
43
-2
COF
68
3
EW
53
3
BXP
62
2
MCHP
62
2
UNM
68
-3
AMP
78
2
PHM
74
5
BDX
61
2
LYB
39
-7
EL
56
3
JWN
73
-3
ADSK
57
5
YUM
62
4
SYF
85
-5
DVA
75
2
IR
85
5
TRV
45
-4
ZTS
63
3
AN
61
-2
GPC
43
-2
COF
68
3
EW
53
3
BXP
62
2
MCHP
62
2
UNM
68
-3
AMP
78
2
PHM
74
5
BDX
61
2
LYB
39
-7
Financhill
Back

PROCEPT BioRobotics 10K Form

Buy
96

PRCT
PROCEPT BioRobotics

Last Price:
68.15
Seasonality Move:
13.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $136.19M
Cash Flow: $-34.23M
Price / Cash Flow: 0
Annual Sales: $5.14
Price / Book: 13.48

Profitability

EPS (TTM): -2.12000
Net Income (TTM): $-103.37M
Gross Margin: $71.05M
Return on Equity: -44.06%
Return on Assets: -29.27%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRCT is 52.17%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 96.76% of Gross Profit Margin.
  • The Research & Development expenses have been 35.57% of Revenue.
  • The Interest Expense is -3.77% of Operating Income.
  • The Net Earning history of PRCT is -77.76% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 8.52
Quick Ratio: 7.29

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Buy
96
PROCEPT BioRobotics (PRCT) is a Buy

Is PROCEPT BioRobotics a Buy or a Sell?